Company / Current Assets per Share
Avalo Therapeutics, Inc. Current Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$10.05
FY2025
5-year range
$0.82 / $213.65
FY2021-FY2025
Trend
-94.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $213.65 to $10.05 over the past 2 years.
Based on SEC 10-K filings.
10.05 in FY2025 with a 5-year CAGR of +76.6%.
Declined from $213.65 to $10.05 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +79.2%
- 5-Year CAGR
- +76.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 94.2% year-over-year.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.05 | -94.2% |
| FY2024 | $173.23 | -18.9% |
| FY2023 | $213.65 | +12133.0% |
| FY2022 | $1.75 | +111.8% |
| FY2021 | $0.82 | +40.7% |
| FY2020 | $0.59 | +34.9% |
| FY2019 | $0.43 | -38.1% |
| FY2018 | $0.70 | -38.0% |
| FY2017 | $1.13 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026